Diluted EPS came in at $-0.13 (+13.3% YoY), beat the $-0.14 consensus by $0.01.
Trailing eight quarters through Q1 2025
Common questions about Nautilus Biotechnology, Inc.'s Q1 2025 earnings report.
Nautilus Biotechnology, Inc. (NAUT) reported Q1 2025 earnings on April 29, 2025 before market open.
Nautilus Biotechnology, Inc. reported diluted EPS of $-0.13 for Q1 2025.
EPS beat the consensus estimate of $-0.14 by $0.01.
Compared to the same quarter a year prior, diluted EPS grew 13.3% from $-0.15.
You can read the 8-K earnings release (0001808805-25-000039) and the 10-Q periodic report (0001808805-25-000042) directly on SEC EDGAR. The filing index links above go to sec.gov.